Healthcare Services Group Inc
NASDAQ: HCSG · HEALTHCARE · MEDICAL CARE FACILITIES
Updated 2026-05-06
Healthcare Services Group Inc (HCSG) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for HCSG.
Valued
Valuation reasonably reflects current fundamentals. Limited margin of safety at these levels.
HCSG historical valuation range
Where current P/E sits in HCSG's own 5Y range.
HCSG intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
HCSG valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 22.42x
P/S Ratio — History
Current: 0.79x
Is HCSG overvalued in 2026?
Healthcare Services Group Inc (HCSG) currently trades at $22.07 per share with a market capitalization of $1,462,143,000.00. Based on our multi-factor framework, the stock trades at a fair valuation with a Smart Value Score of 60/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 22.4x, below its 5-year median of 24.1x. The PEG ratio of 1.36 points to a price that reasonably reflects expected earnings growth.
Looking at its own history, HCSG is currently trading cheaper than 77% of the last 5Y on P/E. This places it in the 23th percentile of its historical range, a level that has historically coincided with attractive entry points.
Our discounted cash flow model estimates HCSG's intrinsic value at $115.76 per share, against the current market price of $22.07. This implies a margin of safety of +80.75%. A meaningful cushion exists against model error, making this a reasonable risk-adjusted entry.
The Piotroski F-Score of 5/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.
Bottom line: HCSG trades at a fair valuation on our framework, with a Smart Value Score of 60/100. The valuation is defensible but offers no obvious bargain. Patience or a better entry price may reward disciplined buyers.
Frequently asked questions
Is HCSG overvalued in 2026?
Based on a Smart Value Score of 60/100, HCSG is fairly valued. Price reasonably reflects current fundamentals with limited cushion in either direction.
What is HCSG's fair value?
Our DCF model estimates HCSG's intrinsic value at $115.76 per share, versus the current price of $22.07. This produces a margin of safety of +80.75%.
What P/E ratio does HCSG trade at?
HCSG trades at a P/E of 22.4x on trailing twelve-month earnings, compared to its 5-year median of 24.1x.
Is HCSG a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 60/100 reflects the combined read on growth, quality, and price. The profile is balanced. Best suited for investors with an existing thesis.
How does HCSG's valuation compare to its history?
On P/E, HCSG currently sits in the 23th percentile of its own 5Y range. That is historically cheap relative to where it has traded over the period.
What is HCSG's Smart Value Score?
HCSG's Smart Value Score is 60/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.